We provide you with 20 years of free, institutional-grade data for BFRI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BFRI. Explore the full financial landscape of BFRI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Biofrontera Inc.(NASDAQ:BFRI) 
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy ...
Website: http://www.biofrontera.us.com
Founded: 1997
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
The information provided in this report about BFRI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.